XTX Topco’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-34,601
| Closed | -$1.2M | – | 2369 |
|
2025
Q1 | $1.2M | Buy |
34,601
+21,272
| +160% | +$735K | 0.06% | 454 |
|
2024
Q4 | $366K | Buy |
+13,329
| New | +$366K | 0.03% | 1033 |
|
2024
Q3 | – | Sell |
-12,096
| Closed | -$306K | – | 2084 |
|
2024
Q2 | $306K | Sell |
12,096
-4,460
| -27% | -$113K | 0.03% | 949 |
|
2024
Q1 | $512K | Buy |
16,556
+10,278
| +164% | +$318K | 0.07% | 475 |
|
2023
Q4 | $253K | Buy |
+6,278
| New | +$253K | 0.06% | 767 |
|
2023
Q3 | – | Sell |
-20,248
| Closed | -$348K | – | 1566 |
|
2023
Q2 | $348K | Buy |
+20,248
| New | +$348K | 0.06% | 611 |
|
2023
Q1 | – | Sell |
-36,952
| Closed | -$282K | – | 1273 |
|
2022
Q4 | $282K | Sell |
36,952
-30,518
| -45% | -$233K | 0.06% | 620 |
|
2022
Q3 | $671K | Buy |
+67,470
| New | +$671K | 0.17% | 133 |
|
2022
Q2 | – | Sell |
-15,051
| Closed | -$153K | – | 850 |
|
2022
Q1 | $153K | Buy |
+15,051
| New | +$153K | 0.07% | 456 |
|
2021
Q4 | – | Sell |
-7,174
| Closed | -$336K | – | 686 |
|
2021
Q3 | $336K | Buy |
+7,174
| New | +$336K | 0.11% | 308 |
|